- 2011.12.29
-
Announcement of Execution of Letter of Intent Regarding COX-2 Inhibitor
- 2011.11.11
-
Summary of Financial Results for the 3Q ended September 30, 2011
- 2011.08.01
-
Executive Appointment
- 2011.07.28
-
CJ CheilJedang Co. and RaQualia Sign License Agreement for 5-HT4 Partial Agonist
- 2011.07.20
- RaQualia announces that its common shares were listed on the Osaka Securities Exchange JASDAQ Growth Market today
- 2011.06.16
- RaQualia Receives Approval to List on JASDAQ
- 2011.12.28
- Pharmaceutical Executive Magazine Features RaQualia: December Issue Cover Story Highlights the Company’s Venture Model
- 2011.12.15
- RaQualia Announces Clinical Research Collaboration with Chiba University Hospital
- 2011.12.02
- RaQualia Announced That RaQualia President Was Selected as One of the Three Finalists in the Accelerating Category for 2011 EOY Japan
- 2011.11.14
-
Start of Phase I Study for Acid Pump Antagonist in Korea
- 2011.11.01
- RaQualia’s CEO Featured in "Pharmaceutical Executive Magazine": Selected as One of 30 Leaders Globally Who Have Made a Difference
- 2011.10.14
- RaQualia President will present at the BioCentury "NewsMakers" in the Biotech Industry Conference
-
A Movie Introducing RaQualia Pharma
-
Simple Keys to Understanding RaQualia Pharma's Business
